Search
Menu
Bristol Instruments, Inc. - 872 Series High-Res 4/24 LB

FluoroPharma Inc.

Facebook X LinkedIn Email
FluoroPharma Inc. of Boston, a developer of molecular imaging agents for the PET market, has announced successful Phase I safety results for BFPET, a fluorine-18-labeled tracer for myocardial perfusion imaging. The imaging agent analyzes blood flow in the heart and assesses coronary artery disease in patients.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: September 2008
    BiophotonicsenergyFluoroPharma Inc.molecular imagingmyocardial perfusion imagingNews & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.